Medically Supervised Weight Loss Program

Medically Supervised Weight Loss Program

Medically Supervised Weight Loss Program services located in Aventura, FL

If you have been struggling with chronic weight management for a long time, semaglutide or tirzepatide may be the solution for you. These FDA-approved medications helps reduce appetite, slow down digestion, and help people stick to a healthy diet, leading to gradual and safe weight loss. Additionally, both medications help improve metabolic health by reducing inflammation and regulating blood sugar and cholesterol levels. Its typical once-a-week dosing makes it convenient and easy to use, making them an excellent choice for those looking for a lasting weight loss solution.

Once weekly semaglutide and tirzepatide injections are both medications that have shown promise for weight loss in clinical trials.

  1. Semaglutide:
    • Mechanism of Action: Semaglutide is a GLP-1 receptor agonist originally developed for managing type 2 diabetes. It mimics the action of GLP-1, a hormone that regulates appetite and food intake. It slows gastric emptying, leading to increased feelings of fullness and reduced appetite.
  2. Tirzepatide:
    • Mechanism of Action: Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It works similarly to semaglutide by stimulating GLP-1 receptors to reduce appetite and food intake.


Both medications help you lose weight GRADUALLY AND SAFELY


Can help you keep the WEIGHT OFF

Unlike other weight loss medications, which only work while they’re in your system, semaglutide and tirzepatide has been shown to promote lasting weight loss by helping you stick to a healthy diet and lifestyle even after discontinuing the medication.


Reduce your risk of developing type 2 diabetes by improving your body’s ability to use insulin, as well as reducing inflammation and cholesterol levels.


Most people who take semaglutide experience minimal side effects, such as nausea, headache, and constipation. The most common side effects are usually mild and can often be managed with lifestyle modifications or over-the-counter medications

While semaglutide and tirzepatide can be beneficial for many people with type 2 diabetes, certain groups of people should not use these medications. These include:

  • Type 1 diabetes
  • Under 18 years of age
  • Personal or Family History of pancreatitis
  • Diabetic retinopathy
  • Pregnant or breastfeeding
  • Family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)


Please note our medically supervised program includes baseline bloodwork and initial consultation prior to starting the program. Monthly follow ups and support available. Medication and supllies are given for 3 months period. Please note, no monthy payments are available. Dosage protocol and program eligibility is individually tailored to patients needs and is upon provider's discretion. 


1st round $950 per 3-month supply

2nd round $1150 per 3-month supply

3rd round $1350 per 3-month supply


1st round $1300 per 3-month supply

2nd round $1600 per 3-month supply

3rd round $1900 per 3-month supply